[HTML][HTML] Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - Vaccine, 2015 - Elsevier
Background Although the elderly are at high risk for influenza, the immunogenicity in the
elderly is lower than that in younger adults. We developed the new type of seasonal …

[PDF][PDF] Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - Vaccine, 2015 - cyberleninka.org
abstract Background: Although the elderly are at high risk for influenza, the immunogenicity
in the elderly is lower than that in younger adults. We developed the new type of seasonal …

[PDF][PDF] Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - Vaccine, 2015 - core.ac.uk
abstract Background: Although the elderly are at high risk for influenza, the immunogenicity
in the elderly is lower than that in younger adults. We developed the new type of seasonal …

[PDF][PDF] Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - Vaccine, 2015 - scholar.archive.org
abstract Background: Although the elderly are at high risk for influenza, the immunogenicity
in the elderly is lower than that in younger adults. We developed the new type of seasonal …

Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - Vaccine, 2015 - europepmc.org
Background Although the elderly are at high risk for influenza, the immunogenicity in the
elderly is lower than that in younger adults. We developed the new type of seasonal …

Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - Vaccine, 2015 - infona.pl
Although the elderly are at high risk for influenza, the immunogenicity in the elderly is lower
than that in younger adults. We developed the new type of seasonal influenza vaccine with …

Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Although the elderly are at high risk for influenza, the immunogenicity in the
elderly is lower than that in younger adults. We developed the new type of seasonal …

Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: a …

R Arakane, R Annaka, A Takahama, K Ishida… - 2015 - cabidigitallibrary.org
Background: Although the elderly are at high risk for influenza, the immunogenicity in the
elderly is lower than that in younger adults. We developed the new type of seasonal …

[引用][C] Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - Vaccine, 2015 - Elsevier Limited

[引用][C] Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A …

R Arakane, R Annaka, A Takahama, K Ishida… - 2015